Big Pharma celebrates new year by raising prices on over 250 drugs
by Beth Mole from Ars Technica - All content on (#4XB9R)
(credit: Images Money)
Leading drug makers rang in the new year by once again raising list prices of their drugs-this time on more than 250 of them, according to an analysis reported by Reuters.
Data examined by healthcare research firm 3 Axis Advisors found that major drug makers including Pfizer Inc, GlaxoSmithKline PLC, and Sanofi SA, Bristol-Myers Squibb Co, Gilead Sciences Inc, and Biogen Inc hiked prices this week.
The larger price tags applied to a range of medications, from blood thinners to cancer therapies and treatments for respiratory conditions, HIV, arthritis, and multiple sclerosis.
Read 6 remaining paragraphs | Comments